Cargando…

A Case of Hypophysitis Following Immunization With the mRNA-1273 SARS-CoV-2 Vaccine

The emergence of a novel coronavirus and global pandemic raised the need for the rapid development of new vaccines to reduce the morbidity and mortality associated with Covid-19. Common side effects of these vaccines such as myalgia, arthralgia, nausea, fatigue, and injection site reaction are usual...

Descripción completa

Detalles Bibliográficos
Autores principales: Murvelashvili, Natia, Tessnow, Alex
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474296/
https://www.ncbi.nlm.nih.gov/pubmed/34553641
http://dx.doi.org/10.1177/23247096211043386
_version_ 1784575180948897792
author Murvelashvili, Natia
Tessnow, Alex
author_facet Murvelashvili, Natia
Tessnow, Alex
author_sort Murvelashvili, Natia
collection PubMed
description The emergence of a novel coronavirus and global pandemic raised the need for the rapid development of new vaccines to reduce the morbidity and mortality associated with Covid-19. Common side effects of these vaccines such as myalgia, arthralgia, nausea, fatigue, and injection site reaction are usually self-resolving. Recognition of other potential adverse effects of these novel vaccines is important due to their rapid and widespread distribution. We report a case of a 51-year-old man admitted to Parkland Memorial Hospital with headache, nausea, vomiting, malaise, and diffuse arthralgias 3 days after he received his second mRNA-1273 SARS-CoV-2 vaccination. He was found to have hyponatremia and a low serum cortisol level. Further workup revealed hypopituitarism with central hypothyroidism, hypogonadism, and a subnormal response to cosyntropin. Magnetic resonance imaging revealed a diffusely enlarged pituitary gland consistent with acute hypophysitis. The patient responded well to glucocorticoid and thyroid hormone supplementation and was discharged after 2 days in the hospital. This is the first reported case of hypopituitarism potentially associated with Covid-19 immunization.
format Online
Article
Text
id pubmed-8474296
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-84742962021-09-28 A Case of Hypophysitis Following Immunization With the mRNA-1273 SARS-CoV-2 Vaccine Murvelashvili, Natia Tessnow, Alex J Investig Med High Impact Case Rep Case Report The emergence of a novel coronavirus and global pandemic raised the need for the rapid development of new vaccines to reduce the morbidity and mortality associated with Covid-19. Common side effects of these vaccines such as myalgia, arthralgia, nausea, fatigue, and injection site reaction are usually self-resolving. Recognition of other potential adverse effects of these novel vaccines is important due to their rapid and widespread distribution. We report a case of a 51-year-old man admitted to Parkland Memorial Hospital with headache, nausea, vomiting, malaise, and diffuse arthralgias 3 days after he received his second mRNA-1273 SARS-CoV-2 vaccination. He was found to have hyponatremia and a low serum cortisol level. Further workup revealed hypopituitarism with central hypothyroidism, hypogonadism, and a subnormal response to cosyntropin. Magnetic resonance imaging revealed a diffusely enlarged pituitary gland consistent with acute hypophysitis. The patient responded well to glucocorticoid and thyroid hormone supplementation and was discharged after 2 days in the hospital. This is the first reported case of hypopituitarism potentially associated with Covid-19 immunization. SAGE Publications 2021-09-23 /pmc/articles/PMC8474296/ /pubmed/34553641 http://dx.doi.org/10.1177/23247096211043386 Text en © 2021 American Federation for Medical Research https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Case Report
Murvelashvili, Natia
Tessnow, Alex
A Case of Hypophysitis Following Immunization With the mRNA-1273 SARS-CoV-2 Vaccine
title A Case of Hypophysitis Following Immunization With the mRNA-1273 SARS-CoV-2 Vaccine
title_full A Case of Hypophysitis Following Immunization With the mRNA-1273 SARS-CoV-2 Vaccine
title_fullStr A Case of Hypophysitis Following Immunization With the mRNA-1273 SARS-CoV-2 Vaccine
title_full_unstemmed A Case of Hypophysitis Following Immunization With the mRNA-1273 SARS-CoV-2 Vaccine
title_short A Case of Hypophysitis Following Immunization With the mRNA-1273 SARS-CoV-2 Vaccine
title_sort case of hypophysitis following immunization with the mrna-1273 sars-cov-2 vaccine
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474296/
https://www.ncbi.nlm.nih.gov/pubmed/34553641
http://dx.doi.org/10.1177/23247096211043386
work_keys_str_mv AT murvelashvilinatia acaseofhypophysitisfollowingimmunizationwiththemrna1273sarscov2vaccine
AT tessnowalex acaseofhypophysitisfollowingimmunizationwiththemrna1273sarscov2vaccine
AT murvelashvilinatia caseofhypophysitisfollowingimmunizationwiththemrna1273sarscov2vaccine
AT tessnowalex caseofhypophysitisfollowingimmunizationwiththemrna1273sarscov2vaccine